—

Laboratorios Farmaceuticos ROVI(ROVI.MC)— 同業公司組

數據截至2026-10-12 — 評分每個交易日晚間重新計算。分組標準=首先為共同的Closelook指數成分,其次為產業。Closelook研究日記,不構成投資建議。

Laboratorios Farmaceuticos ROVI的Closelook綜合評分為61/100,在同業公司組內排名第5位(共12家)——組內評分最高的是Halozyme Therapeutics Inc(74/100)。

名稱綜合動能品質估值訊號距52週高點
ROVI.MC Laboratorios Farmaceuticos ROVI61287650warn31.3%
LNTH Lantheus Holdings Inc60707354info10.5%
KNSA Kiniksa Pharmaceuticals Ltd56945719ok4.5%
BHC.TO Bausch Health Companies Inc55667082info22%
GALDY GALDERMA GROUP AG55505726info13.2%
FAGR.BR Fagron NV52425459info11.5%
ALKS Alkermes Plc51505123info27.7%
GRF.MC Grifols S.A.49574278info16.9%
HALO Halozyme Therapeutics Inc74949448ok4.9%
DXCM DexCom Inc66858035bull9.2%
LLY Eli Lilly and Company64739127bull8.8%
ARGX.BR Argen-X63567529info20.7%

評分為Closelook全部涵蓋範圍內的相對讀數——方法論詳見公司評分說明。訊號燈來自每日夜間訊號看板。

FAQ · from the current data · as of 2026-10-12

Quick answers

Laboratorios Farmaceuticos ROVI在Closelook涵蓋範圍內的同業公司有哪些?

分組首先根據共同的Closelook指數成分,其次根據產業:Lantheus Holdings Inc (LNTH)、Kiniksa Pharmaceuticals Ltd (KNSA)、Bausch Health Companies Inc (BHC.TO)、GALDERMA GROUP AG (GALDY)、Fagron NV (FAGR.BR)、Alkermes Plc (ALKS)、Grifols S.A. (GRF.MC)、Halozyme Therapeutics Inc (HALO)等。

ROVI.MC相對同業公司的評分如何?

Laboratorios Farmaceuticos ROVI的綜合評分為61/100,組內排名第5位(共12家),截至2026-10-12;組內最高綜合評分為Halozyme Therapeutics Inc(74/100)。Closelook評分為研究日記讀數,不構成評等或投資建議。

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.